October 27, 2022 12:54 PM EDT
R&D
Manufacturing

Man­u­fac­tur­ing roundup: Symeres buys CRO in New Jer­sey; Cam­brex in­vests $16M+ in Min­neso­ta and Iowa fa­cil­i­ties

Tyler Patchen

News Reporter

Dutch CD­MO Symeres has ac­quired a com­pa­ny to fur­ther strength­en its po­si­tion in the US.

The com­pa­ny is buy­ing Ex­em­pli­fy Bio­Phar­ma, a CRO that pro­vides …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times